Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking

References

• Risau W, Wolburg, H. Development of blood–brain barrier. Trends Neurosci 1990; 13:174-78; PMID:1693235; http://dx.doi.org/10.1016/0166-2236(90)90043-A
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Romero IA. Transporting therapeutics across the blood–brain barrier. Mol Med Today 1996; 2:106-13
   PubMedGoogle Scholar
• Abbott NJ. Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 2002; 200:629-638; PMID:12162730; http://dx.doi.org/10.1046/j.1469-7580.2002.00064.x
   PubMed Web of Science ®Google Scholar
• Begley DJ, Brightman MW. Structural and functional aspects of the blood–brain barrier. Prog Drug Res 2003; 61:40-78
   Google Scholar
• Wolburg H, Lippoldt A. Tight junctions of the blood–brain barrier: development, composition and regulation. Vasc Pharmacol 2002; 38:323-37; http://dx.doi.org/10.1016/S1537-1891(02)00200-8
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. The blood–brain barrier/ neurovascular unit in health and disease. Pharmacol Rev 2005; 57:173-85; PMID:15914466; http://dx.doi.org/10.1124/pr.57.2.4
   PubMed Web of Science ®Google Scholar
• Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, McMa-hon AP. Canonical Wnt signaling regulates organ-specific assemblyand differentiation of CNS vasculature. Science 2008; 322:1247-50; PMID:19023080; http://dx.doi.org/10.1126/science.1164594
   PubMed Web of Science ®Google Scholar
• Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. Wnt/beta-catenin signaling controls development of the blood–brain barrier. J Cell Biol 2008; 183:409-17; PMID:18955553; http://dx.doi.org/10.1083/jcb.200806024
   PubMed Web of Science ®Google Scholar
• Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt/b-cateninsignaling is required for CNS, but not non-CNS, angiogenesis. Proc Nat Acad Sci USA 2009; 106:641-6; http://dx.doi.org/10.1073/pnas.0805165106
   PubMed Web of Science ®Google Scholar
• Tam SJ, Richmond DL, Kaminker JS, Modrusan Z, Martin-McNulty B, Cao TC, Weimer RM, Carano RA, Bruggen N, Watts RJ. Death receptors DR6 and TROY regulate brain vascular development. Dev Cell 2012; 22:403-17
   PubMed Web of Science ®Google Scholar
• Wang Y, Rattner A, Zhou Y, Williams J, Smallwood PM, Nathans J. Norrin/Frizzled4 signaling in retinal vascular development and bloodbrain barrier plasticity. Cell 2012; 151:1332-44; PMID:23217714; http://dx.doi.org/10.1016/j.cell.2012.10.042
   PubMed Web of Science ®Google Scholar
• Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C. Mfsd2a is critical for the formation and function of the blood–brain barrier. Nature 2014; 22:507-11; http://dx.doi.org/10.1038/nature13324
   Web of Science ®Google Scholar
• Rodriguez A, Tatter SB, Debinski W. Neurosurgical techniques for disruption of the blood–brain barrier for glioblastoma treatment. Pharmaceutics 2015; 7:175-87; PMID:26247958; http://dx.doi.org/10.3390/pharmaceutics7030175
   PubMed Web of Science ®Google Scholar
• Atluri VSR, Hidalgo M, Samikkannu T, Kurapati KRV, Jayant RD, Sagar V, Nair MPN. Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 2015; 9:212; PMID:26113810; http://dx.doi.org/10.3389/fncel.2015.00212
   PubMed Web of Science ®Google Scholar
• Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE. AngII-mediated BBB disruption in hypertension. Hypertension 2014; 63:572-79; PMID:24343120; http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.01743
   PubMed Web of Science ®Google Scholar
• Won S, Sayeed I, Peterson BL, Wali B, Kahn JS, Stein DG. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via Vitamin D receptor-mediated NF-kB signaling pathways. Plos One 2015; 10:1-17
   Web of Science ®Google Scholar
• Engelhardt S, Patkar S, Ogunshola OO. Cell-specific blood–brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmaco 2014; 171:1210-30; http://dx.doi.org/10.1111/bph.12489
   PubMed Web of Science ®Google Scholar
• Schreurs MPH, Hubel CA, Bernstein IM, Jeyabalan A, Cipolla MJ. Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. FASEB J 2012; 27:1254-63; http://dx.doi.org/10.1096/fj.12-222216
   PubMed Web of Science ®Google Scholar
• Domínguez A, Suárez-Merino B, de-Cerio FG. J. Nanoparticles and blood-brain barrier: the key to central nervous system diseases. Nanosci Nanotechnol 2014; 14: 766-79; http://dx.doi.org/10.1166/jnn.2014.9119
   PubMed Web of Science ®Google Scholar
• Aly AE-E, Waszczak BL. Intranasal gene delivery for treating Parkinson's disease: overcoming the blood–brain barrier. Expert Opin Drug Deliv 2015; 12:1-19; PMID:26289676; http://dx.doi.org/10.1517/17425247.2015.1069815
   PubMed Web of Science ®Google Scholar
• Covarrubias LS, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des 2014; 20:1422-49; PMID:23789948; http://dx.doi.org/10.2174/13816128113199990463
   PubMed Web of Science ®Google Scholar
• McCall RL, Cacaccio J, Wrabel E, Schwartz ME, Coleman TP, Sirianni RW. Pathogen-inspired drug delivery to the central nervous system, Tissue Barriers 2014; 2:e944449; PMID:25610755; http://dx.doi.org/10.4161/21688362.2014.944449
   PubMedGoogle Scholar
• Wilhelm I, Krizbai IA. In vitro models of the blood−brain barrier for the study of drug delivery to the brain. Mol Pharm 2014; 11:1949-63; http://dx.doi.org/10.1021/mp500046f
   PubMed Web of Science ®Google Scholar
• Bobilya DJ. A model for transport studies of the blood–brain barrier. Methods Mol Biol 2010; 637:149-63; PMID:20419434; http://dx.doi.org/10.1007/978-1-60761-700-6_8
   PubMedGoogle Scholar
• DiL,   (ed.), Kerns EH (ed.). Blood-brain barrier in drug discovery: optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs. New Jersey: John Wiley & Sons, 2015:167-379.
   Google Scholar
• Burgess A, Hynynen K. Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem Neurosci 2013; 4:519−26; PMID:23379618; http://dx.doi.org/10.1021/cn300191b
   PubMedGoogle Scholar
• Costas EP, Fenton EY, Caruncho HJ. Reelin expression in brain endothelial cells: an electron microscopy study. BMC Neurosci 2015; 16:1-8; PMID:25655275; http://dx.doi.org/10.1186/s12868-015-0140-z
   PubMed Web of Science ®Google Scholar
• Salsano E, Marotta G, Manfredi V, Giovagnoli AR, Farina L, Savoiardo M, Pareyson D, Benti R, Uziel G. Brain fluorodeoxyglucose PET in adrenoleukodystrophy. Neurology 2014; 83:981-89; PMID:25098542; http://dx.doi.org/10.1212/WNL.0000000000000770
   PubMed Web of Science ®Google Scholar
• Chao F, Shen Y, Zhang H, Tian M. Multimodality molecular imaging of stem cells therapy for stroke. Bio Med Res Int 2013; 2013:1-16
   Google Scholar
• Yan H, Wang L, Wang J, Weng X, Lei H, Wang X, Jiang L, Zhu J, Lu W, Wei X, Li C. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier. ACS Nano 2012; 6:410-420; PMID:22148835; http://dx.doi.org/10.1021/nn203749v
   PubMed Web of Science ®Google Scholar
• Adanyeguh IM, Rinaldi D, Henry PG, Caillet S, Valabregue R, Durr A, Mochel F. Triheptanoin improves brain energy metabolism in patients with Huntington disease. Neurology 2015; 84:490-5; PMID:25568297; http://dx.doi.org/10.1212/WNL.0000000000001214
   PubMed Web of Science ®Google Scholar
• Stewart PA, Wiley MJ. Developing nervous tissue induces formation of blood–brain barrier characteristics in invading endothelial cells: a study using quail–chick transplantation chimeras. Dev Bio 1981; 84:183-92; http://dx.doi.org/10.1016/0012-1606(81)90382-1
   PubMed Web of Science ®Google Scholar
• Olsson Y, Klatzo I, Sourander P, Steinwall O. Blood–brain barrier to albumin in embryonic new born and adult rats. Acta Neuropathol 1968; 10:117-22; PMID:5707962; http://dx.doi.org/10.1007/BF00691305
   PubMed Web of Science ®Google Scholar
• Tauc M, Vignon X, Bouchaud C. Evidence for the effectiveness of the blood–CSFbarrier in the fetal rat choroid plexus. A freeze-fracture and peroxidase diffusion study. Tissue Cell 1984; 16:65-74; PMID:6701893; http://dx.doi.org/10.1016/0040-8166(84)90019-3
   PubMed Web of Science ®Google Scholar
• Saunders NR. Development of the blood–brain barrier to macromolecules. In: Segal MB, ed. Barriers fluids eye brain. London: Macmillan Press; 1992.
   Google Scholar
• Moos T, Møllgård K. Cerebrovascular permeability to azo dyes and plasma proteins in rodents of different ages. Neuropathol Appl Neurobiol 1993; 19:120-7; PMID:8316332; http://dx.doi.org/10.1111/j.1365-2990.1993.tb00416.x
   PubMed Web of Science ®Google Scholar
• Keep RF, Ennis SR, Beer ME, Betz AL. Developmental changes in blood–brainbarrier potassium permeability in the rat: relation to brain growth. J Physiol 1995; 488(Pt 2):439-48; PMID:8568682; http://dx.doi.org/10.1113/jphysiol.1995.sp020978
   PubMed Web of Science ®Google Scholar
• Saunders NR, Knott GW, Dziegielewska KM. Barriers in the immature brain. Cell Mol Neurobiol 2000; 20:29-40; PMID:10690500; http://dx.doi.org/10.1023/A:1006991809927
   PubMed Web of Science ®Google Scholar
• Liebner S, Plate KH. Differentiation of the brain vasculature: the answer came blowing by the Wnt. J Angiogenes Res 2010; 2:1
   PubMedGoogle Scholar
• Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M, Roncali L. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 2004; 122:51-9; PMID:15221411; http://dx.doi.org/10.1007/s00418-004-0665-1
   PubMed Web of Science ®Google Scholar
• Grontoft O. Intracranial haemorrhage and blood–brain barrier problems in the new-born; a pathologico-anatomical and experimental investigation. Acta Pathol Microbiol Scand Suppl 1954; 8:100-9
   Google Scholar
• Hartmann C, Zozulya A, Wegener J, Galla HJ. The impact of glia-derived extracellular matrices on the barrier function of cerebralendothelial cells: an in vitro study. Exp Cell Res 2007; 313:1318-25; PMID:17346702; http://dx.doi.org/10.1016/j.yexcr.2007.01.024
   PubMed Web of Science ®Google Scholar
• Serlin Y, Shelef I, Knyazer B, Friedman A. Anatomy and physiology of the blood–brain barrier. Semin Cell Dev Biol 2015; 38:2-6; http://dx.doi.org/10.1016/j.semcdb.2015.01.002
   PubMed Web of Science ®Google Scholar
• Raab S, Beck H, Gaumann A, Yuce A, Gerber HP, Plate K, Hammes HP, Ferrara N, Breier G. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91:595-605; PMID:14983237
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-77; PMID:12810700; http://dx.doi.org/10.1083/jcb.200302047
   PubMed Web of Science ®Google Scholar
• Abbott NJ. Anatomy and physiology of the blood–brain barriers. In: Udenaes M, de Lange ECM, Thorne RG, editors. Drug Delivery to the Brain SE – 1, vol. 10. New York: Springer; 2014. pp. 3-21.
   Google Scholar
• Nienke R. Wevers NR, E. de Vries H. Morphogens and blood-brain barrier function in health and disease. Tissue Barriers 2015
   Web of Science ®Google Scholar
• Gu C, Rodriguez ER, Reimert DV, Shu T, Fritzsch B, Richards LJ, Kolodkin AL, Ginty DD. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5:45-57; PMID:12852851; http://dx.doi.org/10.1016/S1534-5807(03)00169-2
   PubMed Web of Science ®Google Scholar
• Alvarez JI, Devillers AD, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M et al. The Hedgehog pathway promotes blood–brain barrier integrityand CNS immune quiescence. Science 2011; 334:1727-31; PMID:22144466; http://dx.doi.org/10.1126/science.1206936
   PubMed Web of Science ®Google Scholar
• Risau W, Hallmann R, Albrecht U. Differentiation dependent expression of proteins in brain endothelium during development of the blood brain barrier. Dev Biol 1986; 117:537-45; PMID:2875908; http://dx.doi.org/10.1016/0012-1606(86)90321-0
   PubMed Web of Science ®Google Scholar
• Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR. Barriers in the developing brain and Neurotoxicology. Neurotoxicology 2012; 33:586-604; PMID:22198708; http://dx.doi.org/10.1016/j.neuro.2011.12.009
   PubMed Web of Science ®Google Scholar
• Reyahi A, Nik AM, Ghiami M, Linde AG, Pontén F, Johansson BR, Carlsson P. Foxf2 is required for brain pericyte differentiationand development and maintenance of the blood-brain barrier. Dev Cell 2015; 6:19-32; http://dx.doi.org/10.1016/j.devcel.2015.05.008
   Web of Science ®Google Scholar
• Mizee MR, de Vries HE. Blood-brain barrier regulation. Tissue Barriers 2015; 1:5, e26882; http://dx.doi.org/10.4161/tisb.26882
   Google Scholar
• Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45:545-52; PMID:15186921; http://dx.doi.org/10.1016/j.neuint.2003.11.006
   PubMed Web of Science ®Google Scholar
• Nag S, David JB. Blood Brain Barrier, Exchange of metabolites and gases. In Kalimo H, editor, Pathology and Genetics: Cerebrovascular Diseases. Basel: ISN Neuropath Press. 2005. p.22-29.
   Google Scholar
• Brown RC, Mark KS, Egleton RD, Davis TP. Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol 2004; 286:C1045-C1052; PMID:15075203; http://dx.doi.org/10.1152/ajpcell.00360.2003
   PubMedGoogle Scholar
• Cserr H, Cooper DN, Suri PK, Patlak CS. Efflux of radiolabeled polyethylene glycol and albumin from rat brain. Am J Physiol 1981; 240:F319-F328; PMID:7223889
   PubMed Web of Science ®Google Scholar
• Cserr HF, Patlak CS. Secretion and bulk flow of interstitial fluid. In: Bradbury MWB (Ed.), Physiology and Pharmacology of the Blood–Brain Barrier. Heidelberg: Springer 1992; pp.245-61.
   Google Scholar
• Dolman D, Drndarski S, Abbott NJ, Rattray M. Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem 2005; 93:825-33; PMID:15857386; http://dx.doi.org/10.1111/j.1471-4159.2005.03111.x
   PubMed Web of Science ®Google Scholar
• Milhorat TH, Hammock MK, Fenstermacher JD, Levin VA. Cerebrospinal fluid production by the choroid plexus and brain. Science 1971; 173:330-32; PMID:4997797; http://dx.doi.org/10.1126/science.173.3994.330
   PubMed Web of Science ®Google Scholar
• Davson H, Segal MB. Physiology of the CSF and blood–brain barriers. Boca Raton, USA: CRC Press. 1995.
   Google Scholar
• Abbott NJ, Rönnbäck L, Hansson E. Astrocyte–endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7:41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824
   PubMed Web of Science ®Google Scholar
• Kandel ER, Schwartz JH, Jessel TM. Principles of Neural Science, 4th Ed. New York: McGraw-Hill, 2000. pp.1294.
   Google Scholar
• Hammarlund-Udenaes M, Fridén M, Syvanen S, Gupta A. On the rate and extent of drug delivery to the brain. Pharm Res 2008; 25:1737-50; PMID:18058202; http://dx.doi.org/10.1007/s11095-007-9502-2
   PubMed Web of Science ®Google Scholar
• Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC. The blood-brain barrier: an engineering perspective. Front Neuroeng 2013; 6:1-22; PMID:23443302; http://dx.doi.org/10.3389/fneng.2013.00007
   PubMedGoogle Scholar
• Nicholson C, Zare PK, Tao L. Brain extracellular space as a diffusion barrier. Comput Vis Sci 2011; 14:309-25; PMID:23172993; http://dx.doi.org/10.1007/s00791-012-0185-9
   PubMedGoogle Scholar
• Deo AK, Theil FP, Nicolas JM. Confounding parameters in preclinical assessment of blood-brain barrier permeation: an overview with emphasis on species differences and effect of disease states. Mol Pharm 2013; 10:1581-95; PMID:23256608; http://dx.doi.org/10.1021/mp300570z
   PubMed Web of Science ®Google Scholar
• Popescu BO, Toescu EC, Popescu LM, Bajenaru O, Muresanu DF, Schultzberg M, Bogdanovic N. Blood-brain barrier alterations in ageing and dementia. J Neurol Sci 2009; 283:99-106
   PubMed Web of Science ®Google Scholar
• Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010; 468:562-6; PMID:20944625; http://dx.doi.org/10.1038/nature09513
   PubMed Web of Science ®Google Scholar
• Dorovini-Zis K., ed. The blood-brain barrier in health and disease, volume 2: pathophysiology and pathology. Boca Raton: CRC press, 2015; 5-6
   Google Scholar
• Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32:8-86
   Web of Science ®Google Scholar
• Wolka AM, Huber JD, Davis TP. Pain and the blood-brain barrier: obstacles to drug delivery. Adv Drug Deliv Rev 2003; 55:987-1006; PMID:12935941; http://dx.doi.org/10.1016/S0169-409X(03)00100-5
   PubMed Web of Science ®Google Scholar
• Nishioku T, Furusho K, Tomita A, Ohishi H, Dohgu S, Shuto H, Yamauchi A, Kataoka Y. Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. Neuroscience 2011; 189:286-92; PMID:21627981; http://dx.doi.org/10.1016/j.neuroscience.2011.05.044
   PubMed Web of Science ®Google Scholar
• Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol, Neurosurg Psychiat 2003; 74:70-6; PMID:12486269; http://dx.doi.org/10.1136/jnnp.74.1.70
   PubMed Web of Science ®Google Scholar
• Nguyen JH. Blood-brain barrier in acute liver failure. Neurochem Int 2012; 60:676-83; PMID:22100566; http://dx.doi.org/10.1016/j.neuint.2011.10.012
   PubMed Web of Science ®Google Scholar
• Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol 2011; 110:329-39; PMID:21071591; http://dx.doi.org/10.1152/japplphysiol.01159.2010
   PubMed Web of Science ®Google Scholar
• Tang JP, Rakhit A, Douglas FL, Melethil S. Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril. Pharm Res 1992; 9:236-43; PMID:1553348; http://dx.doi.org/10.1023/A:1018945608888
   PubMed Web of Science ®Google Scholar
• Ong WY, Halliwell B. Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann NY Acad Sci 2004; 1012:51-64; http://dx.doi.org/10.1196/annals.1306.005
   PubMed Web of Science ®Google Scholar
• Patel JP and Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast 2015; 2015:1-12.
   Web of Science ®Google Scholar
• Fonseca ACC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, Lima FRS. The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 2014; 8:362
   PubMed Web of Science ®Google Scholar
• Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. J Autoimmun 2015; 60:40-50; PMID:25911200; http://dx.doi.org/10.1016/j.jaut.2015.03.005
   PubMed Web of Science ®Google Scholar
• Gorter JA, van Vliet EA, Aronica E. Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis. Epilepsy Behav 2015; 49:13-6; PMID:25958228; http://dx.doi.org/10.1016/j.yebeh.2015.04.047
   PubMed Web of Science ®Google Scholar
• Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998; 44:592-600; PMID:9778257; http://dx.doi.org/10.1002/ana.410440404
   PubMed Web of Science ®Google Scholar
• Kim BJ, Hancock BM, Bermudez A, Cid ND, Reyes E, Sorge NM, Lauth X, Smurthwaite CA, Hilton BJ, Stotland A, Banerjee A, Buchanan J, Wolkowicz R, Traver D, Doran KS. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest 2015; 125:2473-83; http://dx.doi.org/10.1172/JCI74159
   PubMed Web of Science ®Google Scholar
• Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013; 19: 1584-96; PMID:24309662; http://dx.doi.org/10.1038/nm.3407
   PubMed Web of Science ®Google Scholar
• Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. Polymeric nanoparticles for the drug delivery to the central nervous system. Exp OpinDrug Deliv 2008; 5:155-74; http://dx.doi.org/10.1517/17425247.5.2.155
   PubMed Web of Science ®Google Scholar
• Montenegro L, Trapani A, Latrofa A, Puglisi G. In vitro evaluation on a model of blood brain barrier of idebenone loaded solid lipid nanoparticles. J Nanosci Nanotechnol 2012; 12:330-7; PMID:22523983; http://dx.doi.org/10.1166/jnn.2012.5174
   PubMed Web of Science ®Google Scholar
• Re F, Cambianica I, Zona C, Sesana S, Gregori M, Rigolio R, Ferla BL, Nicotra F, Forloni G, Cagnotto A. Functionalization of liposomes with ApoEderived peptides at different density affects cellular uptake and drug transport across a blood–brain barrier model. Nanomedicine 2011; 7:551-9; PMID:21658472; http://dx.doi.org/10.1016/j.nano.2011.05.004
   PubMed Web of Science ®Google Scholar
• Yemisci M, GürsoyÖzdemir Y, Caban S, Bodur E, Capan Y, Dalkara T. Transport of a caspase inhibitoracross the blood-brain barrier by chitosan nanoparticles. Methods Enzymol 2012; 508:253-69; PMID:22449930; http://dx.doi.org/10.1016/B978-0-12-391860-4.00013-6
   PubMed Web of Science ®Google Scholar
• Beg S, Samad A, Alam MI, Nazish I. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol Disord Drug Targets 2011; 10:576-88; PMID:21631401; http://dx.doi.org/10.2174/187152711796235023
   PubMed Web of Science ®Google Scholar
• Li Y, He H, Jia X, Lu WL, Lou J, Wei Y.A dual targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferring and tamoxifen for treating brain gliomas. Biomaterials 2012; 33:3899-908; PMID:22364698; http://dx.doi.org/10.1016/j.biomaterials.2012.02.004
   PubMed Web of Science ®Google Scholar
• Vinogradov SV, Poluektova LY, Makarov E, Gerson T, Senanayake MT. NanoNRTIs: efficient inhibitors of HIV type1 in macrophages with a reduced mitochondrial toxicity. Antivir Chem Chemother 2010; 21:1-14; PMID:21045256; http://dx.doi.org/10.3851/IMP1680
   PubMedGoogle Scholar
• Chen YC, Hsieh WY, Lee WF, Zeng DT. Effects of surface modification of PLGA–PEG–PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier. J Biomater Appl 2011; 27:909-22; PMID:22207601; http://dx.doi.org/10.1177/0885328211429495
   PubMed Web of Science ®Google Scholar
• Silva AC, Oliveira TR, Mamani JB, Malheiros SM, Malavolta L, Pavon LF, Sibov TT, Amaro E Jr, Tannus A, Vidoto EL, et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed 2011; 6:591-603; PMID:21674016
   PubMed Web of Science ®Google Scholar
• Takagi H, Azuma K, Tsuka T. Antitumor effects of hightemperature hyperthermia on a glioma rat model. Oncol Lett 2014; 7:1007-10; PMID:24944659
   PubMed Web of Science ®Google Scholar
• Titsworth W, Murad GJ, Hoh BL, Rahman M. Fighting fire with fire: the revival of thermotherapy for gliomas. Anticancer Res 2014; 34:565-574; PMID:24510985
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007; 121:901-7; PMID:17437269; http://dx.doi.org/10.1002/ijc.22732
   PubMed Web of Science ®Google Scholar
• Wang DC, Zhang Y, Chen HY, Li XL, Qin LJ, Li YJ, Zhang HY, Shuo Wang S. Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells. Asian Pacific J Cancer Prev 2012; 13:3239-45; http://dx.doi.org/10.7314/APJCP.2012.13.7.3239
   PubMedGoogle Scholar
• Kiessling M, Herchenhan E, Eggert HR. Cerebrovascular and metabolic effects on the rat brain of focal Nd:YAG laser irradiation. J Neurosurg 1990; 73:909-17; PMID:2230973; http://dx.doi.org/10.3171/jns.1990.73.6.0909
   PubMed Web of Science ®Google Scholar
• Choi M, Ku T, Chong K, Yoon J, Choi C. Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability. Proc Natl Acad Sci USA 2011; 108: 9256-61; http://dx.doi.org/10.1073/pnas.1018790108
   PubMed Web of Science ®Google Scholar
• Tabatabaei SN, Girouard H, Carret AS, Martel S. Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery. J Control Rel 2015; 206: 49-57; PMID:25724273; http://dx.doi.org/10.1016/j.jconrel.2015.02.027
   PubMed Web of Science ®Google Scholar
• Descamps L, Dehouck MP, Torpier G, Cecchelli R. Receptor-mediated transcytosis of transferring through blood-brain barrier endothelial cells. Am J Physiol 1996; 270:1149-58;
   PubMed Web of Science ®Google Scholar
• Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138:877-89; PMID:9265653; http://dx.doi.org/10.1083/jcb.138.4.877
   PubMed Web of Science ®Google Scholar
• Candela P, Gosselet F, Miller F, Scherrer VB, Torpier G, Cecchelli R, Fenart L. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium 2008; 15:254-64; PMID:19065317; http://dx.doi.org/10.1080/10623320802487759
   PubMed Web of Science ®Google Scholar
• Chung NS, Wasan KM. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev 2004; 56:1315-34; PMID:15109771; http://dx.doi.org/10.1016/j.addr.2003.12.003
   PubMed Web of Science ®Google Scholar
• Gao X, Qian J, Zheng S, Changyi Y, Zhang J, Ju S, Zhu J, Li C. Overcoming the blood brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. ACS Nano 2014; 8:3678-89; PMID:24673594; http://dx.doi.org/10.1021/nn5003375
   PubMed Web of Science ®Google Scholar
• Sebbage V. Cell-penetrating peptides and their therapeutic applications. Biosci Horizons 2009; 2:64-72; http://dx.doi.org/10.1093/biohorizons/hzp001
   Google Scholar
• Zou LL, Ma JL, Wang T, Yang TB, Liu CB. Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system. Curr Neuropharmacol 2013; 11:197-208; PMID:23997754; http://dx.doi.org/10.2174/1570159X11311020006
   PubMed Web of Science ®Google Scholar
• Roger M, Clavreul A, Julienne MCV, Passirani C, Sindji L, Schiller P, Menei CM, Menei P. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010; 31:8393-401; PMID:20688391; http://dx.doi.org/10.1016/j.biomaterials.2010.07.048
   PubMed Web of Science ®Google Scholar
• Fan C, Wang D, Zhang Q, Zhou J. Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo. Neural Regen Res 2013; 8:2093-102; PMID:25206518
   PubMed Web of Science ®Google Scholar
• Ebrahimi A, Lalvand N. Drug delivery using genetically modified mesenchymal stem cells: a promising targeted-delivery method. Hyg J Drugs Med 2013; 5:90-104
   Google Scholar
• Gonda I. Systemic delivery of drugs to humans via inhalation. J Aerosol Med 2006, 19:47-53; PMID:16551214; http://dx.doi.org/10.1089/jam.2006.19.47
   PubMedGoogle Scholar
• Ewart W. The use of creosoted oil for the expulsion of tracheal false membranes after tracheotomy; and of intranasal injections of oil in various affection. Br Med J 1898; 1:1381-83; PMID:20757845; http://dx.doi.org/10.1136/bmj.1.1952.1381
   PubMedGoogle Scholar
• Wu S. Intranasal delivery of neural stem cells: a CNS specific, non-invasive cell-based therapy for experimental autoimmune encephalomyelitis. J Clin Cell Immunol 2013; 1:4; PMID:24244890
   PubMedGoogle Scholar
• Ueno H, Mizuta M, Shiiya T, Tsuchimochi W, Noma K, Nakashima N, Fujihara M, Nakazato M. Exploratory trial of intranasal administration of glucagon-like Peptide-1 in Japanese patients with type 2 diabetes. Diabetes Care 2014; 37:2024-27; PMID:24667460; http://dx.doi.org/10.2337/dc13-0690
   PubMed Web of Science ®Google Scholar
• Rapoport SI. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell. Mol. Neurol. 2000; 20:217-30; http://dx.doi.org/10.1023/A:1007049806660
   PubMed Web of Science ®Google Scholar
• Miyake MM, Bleier BS. Bypassing the blood–brian barrier using established skull base reconstruction techniques. WJO 2015; 1:11-16
   Google Scholar
• Griep LM, Wolbers F, Wagenaar B, Braak PM, Weksler BB, Romero IA, Couraud PO, Vermes I, Meer AD, Berg A. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices 2013; 15:145-50; http://dx.doi.org/10.1007/s10544-012-9699-7
   PubMed Web of Science ®Google Scholar
• Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood brain barrier (mBBB). Lab Chip 2012; 12:1784-92; PMID:22422217; http://dx.doi.org/10.1039/c2lc40094d
   PubMed Web of Science ®Google Scholar
• Shayan G, Choi YS, Shusta EV, Shuler ML, Lee KH. Murine in vitro model of the blood-brain barrier for evaluating drug transport. Eur J Pharm Sci 2011; 42:148-55; PMID:21078386; http://dx.doi.org/10.1016/j.ejps.2010.11.005
   PubMed Web of Science ®Google Scholar
• Shayan G, Shuler ML, Lee KH. The effect of astrocytes on the induction of barrier properties in aortic endothelial cells. Biotechnol Prog 2011; 27:1137-45; PMID:21626719; http://dx.doi.org/10.1002/btpr.620
   PubMed Web of Science ®Google Scholar
• Molino Y, Jabès F, Lacassagne E, Gaudin N, Khrestchatisky M. Setting-up an in vitro model of rat blood-brain barrier (BBB): afocus on BBB impermeability and receptor-mediated transport. J Vis Exp 2014; 88:512-78
   Google Scholar
• Achyuta AKH, Conway AJ, Crouse RB, Bannister EC, Lee RN, Katnik CP, Behensky AA, Cuevas J, Sundaram SS. A modular approach to create a neurovascular unit-on-a-chip. Lab Chip 2013; 13:542-53; PMID:23108480; http://dx.doi.org/10.1039/C2LC41033H
   PubMed Web of Science ®Google Scholar
• Shi M, Majumdar D, Gao Y. Brewer BM, Goodwin CR, McLean JA, Li D, Webb DJ. Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip 2013; 13:3008-21; PMID:23736663; http://dx.doi.org/10.1039/c3lc50249j
   PubMed Web of Science ®Google Scholar
• Park HS, Liu S, McDonald J, Thakor N, Yang IH. Neuromuscular junction in a microfluidic device. Conf IEEE Eng Med Biol Soc 2013:2833-35
   PubMedGoogle Scholar
• Ziegler L, Grigoryan S, Yang IH, Thakor, NV, Goldstein RS. Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev 2011; 7:394-403; PMID:21052870; http://dx.doi.org/10.1007/s12015-010-9198-2
   PubMed Web of Science ®Google Scholar
• Kunze A, Lengacher S, Dirren E, Aebischer P, Magistrettic PJ, Renaud P. Astrocyte-neuron co-culture on microchips based on the model of SOD mutation to mimic ALS. Integr Biol (Camb) 2013; 5:964-75; PMID:23695230; http://dx.doi.org/10.1039/c3ib40022k
   PubMed Web of Science ®Google Scholar
• Roe K, Orillo B, Verma S. West nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model. Plos One 2014; 9:1-12; http://dx.doi.org/10.1371/journal.pone.0102598
   Web of Science ®Google Scholar
• Xiong X, Sun Y, Sattiraju A, Jung Y, Mintz A, Hayasaka S, Li KCP. Remote spatiotemporally controlled and biologically selective permeabilization of blood-brain barrier. J Control Release 2015; 217:113-20; PMID:26334482
   PubMed Web of Science ®Google Scholar
• Cucullo L, Marchi N, Hossain M, Janigro D. A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system. J Cereb Blood Flow Metab 2011; 31:767-77; PMID:20842162
   PubMed Web of Science ®Google Scholar
• Czupalla CJ, Liebner S, Devraj K. In vitro models of the blood-brain barrier. Methods Mol Biol 2014; 1135:415-37; PMID:24510883
   PubMedGoogle Scholar
• Wolff A, Antfolk M, Brodin B, Tenje M. In vitro blood–brain barrier models—An overview of established models and new microfluidic approaches. J Pharm Sci 2015; 104:2727-46.
   PubMed Web of Science ®Google Scholar
• Wager TT, Liras JL, Mente S, Trapa P. Strategies to minimize CNS toxicity: in vitro high throughput assays and computational modeling. Expert Opin Drug Metab Toxicol 2012;8: 531-42.
   PubMed Web of Science ®Google Scholar
• Ruck T, Bittner S, Meuth SG. Blood brain barrier modeling: challenges and perspectives. Neural Regen Res 2015;10:889-91.
   PubMed Web of Science ®Google Scholar
• Prager O, Chassidim Y, Klein C, Levi H, Shelef I, Friedman A. Dynamic in vivo imaging of cerebral blood flow and blood–brain barrier permeability. Neuroimage 2010; 49:337-44.
   PubMed Web of Science ®Google Scholar
• Greenwood J, Adu J, Davey AJ, Abbott NJ, Bradbury MW. The effect of bile salts on the permeability and ultrastructure of the perfused, energy-depleted, rat blood–brain barrier. Off J Int Soc Cereb Blood Flow Metabol 1991; 11:644-54.
   PubMed Web of Science ®Google Scholar
• Watson BD, Dietrich WD, Prado R, Ginsberg MD. Argon laser-induced arterial photo thrombosis. J Neurosurg 1987; 66:748-54.
   PubMed Web of Science ®Google Scholar
• Dunn AK. Laser speckle contrast imaging of cerebral blood flow. Ann Biomed Eng 2012; 40:367-77.
   PubMed Web of Science ®Google Scholar
• Wunder A, Klohs J, Dirnagl U. Non-invasive visualization of CNS inflammation with nuclear and optical imaging. Neuroscience 2009; 158:1161-73.
   PubMed Web of Science ®Google Scholar
• Pike VW. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 2009; 30:431-40.
   PubMed Web of Science ®Google Scholar
• Wolak DJ, Pizzo ME, Thorne RG. Probing the extracellular diffusion of antibodies in brain using in vivo integrative optical imaging and ex vivo fluorescence imaging. J Control Release 2015; 197:78-86.
   PubMed Web of Science ®Google Scholar
• Josserand V, Pélerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, Ducongé F, Boisgard R, Beuvon F, Chassoux F, et al. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier. J Pharmacol Exp Ther 2006; 316:79-86.
   PubMed Web of Science ®Google Scholar
• Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 2013; 10:1492-1504.
   PubMed Web of Science ®Google Scholar
• Sykova E, Nicholson C. Diffusion in brain extracellular space. Physiol Rev 2008; 88:1277-1340.; http://dx.doi.org/10.1152/physrev.00027.2007
   PubMed Web of Science ®Google Scholar
• Nicholson C, Tao L. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J 1993; 65:2277-90.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Hrabetova S, Nicholson C. Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging. J Neurophysiol 2004; 92:3471-81; http://dx.doi.org/10.1152/jn.00352.2004
   PubMed Web of Science ®Google Scholar
• Aswendt M, Henn N, Michalk S, Schneider G, Steiner MS, Bissa U, Dose C, Hoehn M. Novel bimodal iron oxide particles for efficient tracking of human neural stem cells in vivo. Nanomedicine 2015; 10; 16:2499-512.; http://dx.doi.org/10.2217/nnm.15.94
   PubMed Web of Science ®Google Scholar
• Yin Y, Zhou X, Guan X, Liu Y, Jiang C, Liu J. In vivo tracking of human adipose-derived stem cells labeled with ferumoxytol in rats with middle cerebral artery occlusion by magnetic resonance imaging. Neural Regener Res 2015; 10:909-15; http://dx.doi.org/10.4103/1673-5374.158355
   PubMed Web of Science ®Google Scholar